Pacific Biosciences of California, Inc. (NASDAQ: PACB)
$2.0900
-0.0100 ( +2.96% ) 13.3M
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Market Data
Open
$2.0900
Previous close
$2.1000
Volume
13.3M
Market cap
$618.06M
Day range
$1.9760 - $2.2050
52 week range
$1.1600 - $8.4800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 20, 2024 |
4 | Insider transactions | 1 | Aug 20, 2024 |
10-q | Quarterly Reports | 77 | Aug 09, 2024 |
8-k/a | 8K-related | 13 | Aug 07, 2024 |
8-k | 8K-related | 14 | Aug 07, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |